Dermata Therapeutics, Inc.
DRMA
$1.27
$0.010.74%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 137.92% | -24.08% | 31.00% | 105.32% | -57.49% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 80.98% | -23.54% | 4.41% | -19.68% | -19.94% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 159.52% | -70.00% | -94.46% | -97.85% | -86.18% |
| Total Current Assets | 122.52% | -24.16% | 26.81% | 93.15% | -55.71% |
|
|
|||||
| Total Current Assets | 122.52% | -24.16% | 26.81% | 93.15% | -55.71% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 122.52% | -24.16% | 26.81% | 93.15% | -55.71% |
|
|
|||||
| Total Accounts Payable | -42.97% | -47.50% | -68.83% | 69.64% | -6.70% |
| Total Accrued Expenses | 1.27% | -39.22% | 3.62% | 138.26% | 53.75% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -16.85% | -42.90% | -46.50% | 97.10% | 21.51% |
|
|
|||||
| Total Current Liabilities | -16.85% | -42.90% | -46.50% | 97.10% | 21.51% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -16.85% | -42.90% | -46.50% | 97.10% | 21.51% |
|
|
|||||
| Common Stock & APIC | 18.18% | 11.99% | 20.15% | 24.78% | 12.54% |
| Retained Earnings | -11.51% | -14.15% | -17.40% | -20.27% | -23.02% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 298.65% | -16.47% | 69.20% | 91.73% | -75.44% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 298.65% | -16.47% | 69.20% | 91.73% | -75.44% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 298.65% | -16.47% | 69.20% | 91.73% | -75.44% |
|
|
|||||